深圳市前海安测信息技术有限公司
0755-86239437
  • 国际医学团队
  • 生物IT研究基地
  • 糖尿病早期诊断基地
  • 48家医院合作单位
  • 易特科(安测)博士后流动站

安测新闻

首页 > 关于安测 > 安测新闻 >

在线名医

    深圳市南山区科技园南区高新南七道数字技术园B1栋4层(易特科集团安测慢病干预工程中心)

    易特科(前海安测)接受中央电视台CCTV专访“互联网医疗+人工智能”

    日期:2018-01-18 来源:易特科 浏览次数:

          2018年1月16日,CCTV中央电视台财频道记者组一行三人莅临易特科(前海安测)深圳总部,进行生命IT创新工作的采访和实地拍摄,易特科集团董事长兼CEO张贯京先生接受了专访,畅谈互联网医疗与人工智能的研发与创新。

          张贯京先生提到,近两年,AI(Artificial Intelligence,人工智能)技术飞速发展,对医疗领域不仅仅是一种技术创新,更从生产力角度对传统医疗行业产生变革,除了提高医生的工作效率外,还将作为辅助诊断,大大提高诊断的效率和准确率,使精准医疗成为可能。其中AI+医学影像诊断市场空间巨大,易特科(前海安测)国际化科研团队正在致力于“互联网+大数据+人工智能”在癌症领域的重要应用,通过构建癌症医学影像大数据云平台真正提高癌症诊疗效率,辅助医生判断并最终实现精准医疗。

          与此同时,张贯京先生还介绍到,易特科(前海安测)在智慧医疗和大健康领域,已经结合人工智能进行了探索性的产业化应用。我司自主研发的中医四诊仪、体质辨识仪、治未病服务系统等产品和服务,是利用人工智能技术结合传统中医药理论和信息技术,在中医领域的应用,为提高中医的数字化、信息化、智能化水平做出了重大创新突破,这得到了国家中医药管理局、中国中医科学院、中华中医药学会等诸多领导和专家的充分认可。此外,我司研发团队还将人工智能与医疗健康紧密结合,完成了在智慧医疗领域的创新融合与产业化应用。我们的技术团队采用条件随机场(CRF)、循环神经网络(RNN)、卷积神经网络(CNN)等深度学习算法,解决了自然语言处理(NLP)之中的命名实体识别、实体修饰、文本分类等问题,构建出医学知识图谱,并结合相关决策算法和模型应用于临床数据中心(CDR)、电子病历系统(EMR)、临床信息系统(CIS)、健康体检管理系统(PEIS),实现了临床辅助决策(CDSS)、病历检索与分析(CP)、医学数据挖掘与应用(DATA MINING)等,这样的创新应用在全国,乃至全世界都处于领先突破地位。

          采访拍摄过程中,CCTV采访组对易特科在智慧医疗和人工智能方面的创新探索和产业化商用经验表示高度认可,认为这种前沿的创新医疗服务模式,为广大医疗机构、医护人员、患者及其家属以及社区居民带来了极大的便利,是一项惠及民生的创新探索,非常值得推广。

           深圳市易特科信息技术有限公司注册资本10亿元人民币,是一家拥有15年专业研发和服务背景,专注于生命IT和军工IT的高新技术企业,是国内外领先的生物传感器、生命搜索与定位技术、医疗信息化、健康管理、慢病干预、中医治未病的技术提供商和服务运营商。集团总部设在深圳南山数字技术园,在广州、北京、天津、西安、石家庄、福州、上海、桂林、香港等地设有分支机构,在北爱尔兰、美国硅谷、加拿大多伦多等地设有海外研究院。拥有和运营的健康管理中心近90家,客户遍布全国20多个省市650多家三甲医院、二甲医院和各级医卫机构,华南、华北、华东、西北市场全面开启,智能自助监测一体机、互联网+慢病管理、互联网+急救、互联网+中医、云HIS等医疗信息化产品得到了市场客户广泛好评,业务拓展到加拿大、美国、欧洲等国家和地区。2017年,易特科集团全年营收总额突破16亿元人民币。

          自成立伊始,易特科集团一直坚持走“技术引领,创新驱动”之路,非常重视新产品和新技术的研发,以及知识产权的积累和保护。最新知识产权数据显示,已申请/拥有各类知识产权2899项,申请专利2199项,申请软件著作权295项,申请注册国内外商标33项,域名13个,申请其他知识产权359项;获得授权的知识产权1380项,其中拥有授权专利692项,软件著作权292项,商标22项,域名13个,拥有其他知识产权359项。为了嘉奖易特科在技术创新方面所做的贡献,深圳市知识产权局、广东省知识产权局、国家知识产权局相继授予易特科“深圳市知识产权优势企业”、“广东省知识产权示范企业”、“国家知识产权优势企业”的荣誉。在国家知识产权局刚刚发布的第十九届中国专利奖评审结果中,易特科(前海安测)智慧医疗领域的2项发明专利也荣获了第十九届中国专利奖优秀奖。国家知识产权出版社i智库发布的《全球智慧医疗行业专利发展状况研究报告》显示,易特科集团的2家子公司——深圳市前海安测信息技术有限公司、深圳市易特科信息技术有限公司在全球智慧医疗领域的专利申请排行榜中,分列世界第四、第五位,成为进入榜单前五名的仅有中国企业,是全球智慧医疗专利排名中排名最靠前中国科研机构,前三甲被飞利浦、西门子和通用电气这3家外国公司占据,清华大学和上海交大也进入全球智慧医疗专利前20强,易特科集团排名国内同行业专利第一名和第二名。此外,6月初在北京钓鱼台国宾馆的国家创新颁奖典礼上,凭借在生命IT、大健康和互联网医疗领域的杰出贡献,张贯京先生获评“2017创新中国年度领军人物”,易特科(前海安测)获评“2017创新中国十大领军企业”。

          January 16th, 2018, three members of CCTV financial channel reporter group visited E-Techco (Qianhai AnyCheck) headquarters in Shenzhen to conduct interviews and field shooting of life IT innovation. E-techco Group Chairman and CEO Mr. Zhang Guanjing accepted the interview, talked about the development and innovation of internet medical and artificial intelligence.

          Zhang Guanjing mentioned that in recent two years, AI (Artificial Intelligence, AI) technology has been developing rapidly, which is not only a technological innovation in medical field, but also a change in traditional medical industry from the perspective of productivity. In addition to improving the work efficiency of doctors, it will also be used as an auxiliary diagnosis, greatly improving the efficiency and accuracy of diagnosis, making accurate medical treatment possible. The AI+ medical diagnostic imaging market space is huge, E-Techco (Qianhai AnyCheck) international research team is committed to "Internet plus big data and artificial intelligence" an important application in the field of cancer, cancer medical imaging through the construction of a large data cloud platform to improve cancer treatment efficiency, and finally realize the accurate judgment to assist doctors in medical.

         At the same time, Mr. Zhang Guanjing also introduced that E-Techco (Qianhai AnyCheck) has explored the industrialization application of AI in the field of smart healthcare and big health. Independent research and development of TCM four diagnostic instrument, TCM Constitution identification instrument, disease prevention and service system of products and services, is a combination of traditional Chinese medicine theory and information technology with artificial intelligence technology, the application in the field of traditional Chinese medicine, which has made a major breakthrough innovation to improve the traditional digital information and intelligent level, This has been fully recognized by many leaders and experts from the State Administration of traditional Chinese medicine, the Chinese Academy of Chinese medicine and the Chinese society of Chinese medicine and so on. In addition, our R & D team also combines artificial intelligence with medical health, and has completed the innovative integration and industrial application in the field of intelligent medical treatment. Our technical team using conditional random fields (CRF), recurrent neural network (RNN), convolutional neural network (CNN) and other deep learning algorithms, to solve the Natural Language Processing (NLP) of the named entity recognition, modification, text classification and other issues, to construct the medical knowledge map, and combining with the decision model and algorithm for clinical application the data center (CDR), electronic medical records system (EMR), clinical information system (CIS), health management system (PEIS), the clinical decision support (CDSS), medical record retrieval and analysis (CP), and application of medical data mining (DATA MINING), this innovative application in the country, and even the whole world is in the leading position of breakthrough.

         During the interview, the CCTV interview team highly recognized the E-Techco's innovative exploration of intelligent medical and artificial intelligence and the commercial experience of industrialization. They believe that the cutting-edge innovative medical service mode has brought great convenience to the majority of medical institutions, medical staff, patients and their families and community residents. It is a creative exploration that benefits people's livelihood, and is worth promoting.

          The registered capital of Shenzhen E-Techco Information Technology Co., Ltd. Raised to 1 billion yuan. And E-Techco Group (Qianhai AnyCheck) is a High-Tech enterprise with 15 years R&D and service background, which focuses on Internet & medical & health & geriatric service, and it is in the domestic and overseas leading level of biosensor, life searching and positioning, medical informatization, health management, chronic diseases prevention, TCM preventive medicine technology provider and service practitioner. The company HQ is located in Shenzhen, with branches based in Guangzhou, Beijing, Tianjin, Xian, Shijiazhuang, Fuzhou, Shanghai, Hong Kong, with overseas institutes in north Ireland, American Silicon Valley, Toronto and so on. The number of health management centers owned and operated by E-Techco increased to nearly 90. It has more than 650 grade-2&class-A hospitals, grade 3&class 1 hospitals, and all levels health and medical institutions. The market in Southern China, North China and Northwest China have been fully opened, intelligent self-help integrated machine, internet & chronic disease management, internet & emergency, internet & TCM, cloud HIS and other medical informatization products have been widely acclaimed by customers. Its business expanded to Canada, America, EU and other countries and regions. In 2017, the total annual revenue of etek group exceeded 1.6 billion RMB.

         E-Techco has always attached great importance in self-innovation ability improvement and intellectual property accumulation and protection. According to the latest intellectual property right data, E-Techco has applied 2899 all kinds of intellectual property rights, including 2199 applied patents, including 295 software copyrights, 33 trademarks, 13 domains, 359 other IPs; 1380 authorized intellectual property rights, including 692 intellectual property rights authorizations, 292 software copyrights, 22 trademarks, 13 domains, 359 other IPs. In order to reward E-Techco for its contribution in technological innovation, Shenzhen Intellectual Property Office, Guangdong Provincial Intellectual Property Office and State Intellectual Property Office have granted E-Techco the Shenzhen Intellectual Property Advantage Enterprise and Guangdong Intellectual Property Demonstration Enterprise, National Intellectual Property Advantage Enterprise honor. Among the results of the 19th China Patent Award just released by the State Intellectual Property Office, two invention patents in the field of smart medical treatment of E-Techco (Qianhai AnyCheck) also won the 19th China Patent Award of Excellence. In addition, in the Intellectual Property Publishing House I Think Tank newly published The Intellectual Property Development Conditions Research Report Of Global Smart Medical Industry. E-Techco Groups affiliated enterprises---Qianhai AnyCheck Information Technologies Co. Ltd. E-Techco Information Technologies Co., Ltd respectively was listed in the world fourth and fifth position in the national intellectual property application ranking list in the global smart medical area. It is the only domestic enterprise entering the top 5 list, the top 3 are still occupied by the 3 overseas company Philips, Siemens, General Electric. Tsinghua University and Shanghai Jiao Tong University ranks the top 20 in the global smart medical patent area, while E-Techco Group ranks the first and second among the domestic peers in intellectual property area. In the beginning of June, in the national awarding ceremony held in Beijing Diaoyutai State Guest House, due to his brilliant contributions in Life-IT, big health and internet medical area, John Zhang was awarded 2017 Annual Innovation 2017 Annual Innovation China Leader, and E-Techco was awarded as 2017 Annual Innovation China 10 Leading Enterprise.

    关闭
    • 姓  名

    • 项目套餐

    • 预约电话

    • 预约时间

    预约成功